<DOC>
<DOCNO>EP-0617035</DOCNO> 
<TEXT>
<INVENTION-TITLE>
Heterotricyclic substituted phenylcyclohexanecarboxylic acid derivatives
</INVENTION-TITLE>
<CLASSIFICATIONS>C07D25700	C07D47100	A61K31403	A61P912	A61K31403	A61K31435	C07D20986	C07D40110	A61K3140	A61K3140	C07D20990	A61K3141	A61P900	A61P910	C07D20900	C07D40100	C07D21300	C07D20994	C07D21386	A61P4300	C07D25704	C07D40310	A61K3141	A61P4300	C07D40300	A61K31435	C07D47104	</CLASSIFICATIONS>
<CLASSIFICATIONS-THIRD>C07D	C07D	A61K	A61P	A61K	A61K	C07D	C07D	A61K	A61K	C07D	A61K	A61P	A61P	C07D	C07D	C07D	C07D	C07D	A61P	C07D	C07D	A61K	A61P	C07D	A61K	C07D	</CLASSIFICATIONS-THIRD>
<CLASSIFICATIONS-FOURTH>C07D257	C07D471	A61K31	A61P9	A61K31	A61K31	C07D209	C07D401	A61K31	A61K31	C07D209	A61K31	A61P9	A61P9	C07D209	C07D401	C07D213	C07D209	C07D213	A61P43	C07D257	C07D403	A61K31	A61P43	C07D403	A61K31	C07D471	</CLASSIFICATIONS-FOURTH>
<ABSTRACT>
Heterotricyclic-substituted phenylcyclohexanecarboxylic acid derivatives are prepared by reacting the heterocyclic compounds with cyclohexanecarboxylic acid derivatives which are substituted by benzylhalogen radicals. The compounds can be employed as active ingredients in medicaments.
</ABSTRACT>
<APPLICANTS>
</APPLICANTS>
<INVENTORS>
</INVENTORS>
<CLAIMS>
Heterotricyclically substituted phenyl-cyclohexanecarboxylic 
acid derivatives of the general formula 


 
in which 


A and B
together form a radical of the formula 

D and E
together form a radical of the formula 

 
in which 


R
1
, R
2
 and R
3
are identical or different and denote 
hydrogen or aryl having 6 to 10 carbon atoms, 

which is optionally substituted by hydroxyl, 
halogen or trifluoromethyl or by straight-chain 

or branched alkyl or alkoxy in each case having 
up to 6 carbon atoms, or
 
denote straight-chain or branched alkyl or 

alkenyl in each case having up to 8 carbon 
atoms, or denote cycloalkyl having 3 to 

8 carbon atoms, or denote halogen, 
T
represents a radical of the formula 

 
in which 


R
7
denotes hydrogen or straight-chain or branched 
alkyl having up to 6 carbon atoms, 
R
8
denotes aryl having 6 to 10 carbon atoms, which 
is optionally substituted up to 2 times by 

identical or different substituents from the 
group consisting of halogen, hydroxyl, 

straight-chain or branched alkyl, alkoxy or 
alkoxycarbonyl in each case having up to 

6 carbon atoms, carboxyl, phenoxy and C
3
-C
6
-cycloalkoxy,  
 
R
9
denotes a group of the formula -CH
2
-OR
10
, 
-CO
2
R
11
, -CO-NR
12
R
13
 or pyridyl,
 
in which 
R
10
denotes hydrogen or straight-chain or branched 
alkyl having up to 8 carbon atoms, 
R
11
denotes hydrogen, straight-chain or branched 
alkyl having up to 8 carbon atoms, or phenyl or 

cycloalkyl having 3 to 6 carbon atoms, 
R
12
 and R
13
are identical or different and denote 
hydrogen, straight-chain or branched alkyl 

having up to 8 carbon atoms, or phenyl, 
 
if appropriate in an isomeric form, and their salts. 
Heterotricyclically substituted phenyl-cyclohexanecarboxylic 
acid derivatives according to Claim 1
 
in which 


A and B
together form a radical of the formula 

D and E
together form a radical of the formula 

 
in which 


R
1
, R
2
 and R
3
are identical or different and 
denote hydrogen or phenyl which is optionally 

substituted by hydroxyl, fluorine, chlorine, 
bromine or trifluoromethyl or by straight-chain 

or branched alkyl or alkoxy in each case 
having up to 4 carbon atoms, or
 
denote straight-chain or branched alkyl or 

alkenyl in each case having up to 6 carbon 
atoms, or
 
denote cyclopropyl, cyclobutyl, cyclopentyl, 

cyclohexyl or cycloheptyl, or
 
denote fluorine, chlorine or bromine, 
T
represents a radical of the formula 

 
in which 


R
7
denotes hydrogen or straight-chain or branched 
alkyl having up to 4 carbon atoms, 
R
8
denotes phenyl which is optionally substituted 
by fluorine, chlorine, bromine, hydroxyl, 

straight-chain or branched alkyl, alkoxy or 
alkoxycarbonyl in each case having up to 4 carbon 

atoms, carboxyl or phenoxy, 
R
9
denotes a group of the formula -CH
2
-OR
10
,  
 

-CO
2
R
11
, -CO-NR
12
R
13
 or pyridyl, 
 
in which 


R
10
denotes hydrogen or straight-chain or 
branched alkyl having up to 6 carbon 

atoms, 
R
11
denotes hydrogen, straight-chain or 
branched alkyl having up to 6 carbon 

atoms, phenyl, cyclopropyl, cyclopentyl 
or cyclohexyl, 
R
12
 and R
13
are identical or different and 
denote hydrogen, straight-chain or 

branched alkyl having up to 6 carbon 
atoms, cyclopropyl, cyclopentyl, 

cyclohexyl or phenyl, 
 
if appropriate in an isomeric form, and their salts. 
Heterotricyclically substituted phenyl-cyclohexane-carboxylic 
acid derivatives according to Claim 1
 
in which 


A and B
together form a radical of the formula 

D and E
together form a radical of the formula 

 
in which 


R
1
, R
2
 and R
3
are identical or different and 
denote hydrogen, methyl, fluorine, 

chlorine or bromine, 
T
represents a radical of the formula 

 
in which 
R
7
denotes hydrogen or methyl, 
R
8
denotes phenyl which is optionally substituted 
by fluorine, chlorine, bromine, hydroxyl, 

straight-chain or branched alkyl, alkoxy or 
alkoxycarbonyl in each case having up to 3 carbon 

atoms, carboxyl or phenoxy, 
R
9
denotes a group of the formula -CH
2
-OR
10
, 
-CO
2
-R
11
, -CO-NR
12
R
13
 or pyridyl,
 
in which  

 

R
10
denotes hydrogen or straight-chain or 
branched alkyl having up to 4 carbon 

atoms, 
R
11
denotes hydrogen or straight-chain or 
branched alkyl having up to 4 carbon 

atoms, phenyl, cyclopropyl, cyclopentyl 
or cyclohexyl, 
R
12
 and R
13
are identical or different and 
denote hydrogen or straight-chain or 

branched alkyl having up to 4 carbon 
atoms, cyclopropyl, cyclopentyl, cyclohexyl 

or phenyl, 
 
if appropriate in an isomeric form, and their salts. 
Heterocyclically substituted phenyl-cyclohexanecarboxylic 
acid derivatives according to Claim 1
 
in which 


A and B
together form a radical of the formula 

D and E
together form a radical of the formula 

 
in which 


R
1
, R
2
 and R
3
are identical or different and 
denote hydrogen, bromine or methyl, 
T
represents a radical of the formula 

 
in which 


R
7
denotes hydrogen, 
R
8
denotes phenyl, 
 
and 


R
9
denotes a group -CH
2
OH, 
 
if appropriate in an isomeric form, and their salts. 
Heterotricyclically substituted phenyl-cyclohexane-carboxylic 
acid derivatives according to Claims 1 

to 4 for therapeutic use. 
Process for the preparation of heterotricyclically 
substituted phenyl-cyclohexane-carboxylic acid 

derivatives according to Claims 1 to 4, 
characterized in that  

 
compounds of the general formula (II) 


 
in which 


W
represents a typical leaving group such as, for 
example, chlorine, bromine, iodine, tosylate or 

mesylate, preferably bromine 
 
and 


X
represents C
1
-C
6
-alkoxycarbonyl, 
 
are reacted first with compounds of the general 

formula (III) 

 
in which
 
A, B, D and E have the abovementioned meaning,
 
in inert solvents, if appropriate in the presence of 

a base and if appropriate under a protective gas 
atmosphere, to give compounds of the general 

formula (IV)  
 


 
in which
 
A, B, D, E and X have the abovementioned meaning,
 
and if appropriate starting from the corresponding 

carboxylic acids, the products are subsequently 
amidated in inert solvents, after prior hydrolysis 

and/or activation, with amines of the general 
formula (Va) 


 
in which
 
R
7
, R
8
 and R
9
 have the abovementioned meaning,
 
if appropriate in the presence of a base and/or of 

an auxiliary, for example of a dehydrating agent,
 
and if appropriate the isomers are separated, and in 

the case of the preparation of the salts reacted 
with an appropriate base or acid. 
Medicaments containing at least one heterotricyclically 
substituted phenyl-cyclohexane-carboxylic acid 

derivative according to Claims 1 to 4.  
 
Medicaments according to Claim 7 for the treatment 
of arterial hypertension and atherosclerosis. 
Process for the production of a medicament according 
to Claim 7, characterized in that the active 

compounds are converted into a suitable 
administration form, if appropriate with the aid of 

suitable auxiliaries and excipients. 
Use of heterotricyclically substituted phenyl-cyclohexane-carboxylic 
acid derivatives according to 

Claims 1 to 4 for the production of medicaments. 
</CLAIMS>
</TEXT>
</DOC>
